Skip to main content
. 2012 Jan 31;470(10):2702–2707. doi: 10.1007/s11999-012-2255-1

Table 3.

Bacteria cultured in the 22 SSIsa

Bacteria Cefazolin Cefazolin and vancomycinb
No infection 493 1313
Infection
 MRSAc 4 1
 MSSA 3 6
 CNS 0 4
 Streptococcus varieties 0 2
 Others 3d 6e

SSI = surgical site infection; MRSA = methicillin resistant Staphylococcus aureus; MSSA = methicillin-sensitive Staphylococcus aureus; CNS = coagulative negative Staphylococcus

aThere were seven SSI in the cefazolin group. Multiple organisms grew in multiple sites.

bThere were 15 SSI in the cefazolin and vancomycin group. Multiple organisms grew in multiple sites.

cOdds ratio 95% CI, 29.0 (4.0, 593.3); numbers needed to treat 95% CI, 138.0 (101.5, 2828.2).

dOne each of E coli, Klebsiella, B fragilis.

eOne each of Diptheria, E aerogenes, Enterococcus, Pseudomonas, Acinectobacer, Proteus.